Output Explorer

Strategic Publications Development Meeting
October 19, 2000
Meeting Recap
Attendees:
Wyeth-Ayerst: Jamie Durocher, Mark Barbee, Stephanie Brown, Alice Conti
Design Write: Karen Mittleman (Called In)
General Discussion
DW will include more detailed information on target dates for manuscripts;
"Anti-aging" strategy paper will be incorporated under "Bundle of Benefits"
strategy; Lori Mosca's paper published in Arch Intern Med on Role of HRT in
Prevention of CVD will be moved to CVD section
Grid will need to be filled in with information from Jamie and Gail on which
manuscripts have been distributed, how they've been distributed, and to whom.
Strategic Publications Development
.
Relevance of Clinical Markers for CVD Outcomes (CVD #3)-Alice will follow-
up with Matt Rhoa regarding Ridker based on the concern raised by Pam. DW
will ensure that paper includes data on NF-KB
Healthy Endothelium paper (CVD #5)-Alice will contact Koh. Committee
needs to provide comments on outline to DW by November 1. (Note: Alice has
contacted Koh and he has agreed to author the paper.)
Mammographic Density and HRT (BC #5)-Alice will setup conference call with
Fiorica, Tony, Mark, and DW for week of October 30th. (Note: Conference call
has been scheduled for November 1st.)
Lanes' Clinical Markers for Osteoporosis Outcomes (BB #7)-Alice will follow-
up with Lane and will send her final outline. DW will e-mail Alice the final
outline to send to Lane if she agrees to author the paper. (Note: DW sent outline
to Alice 10/27/00.)
Communicating persistence/usage and awareness data (Rx #5)-Meeting has
been set with legal for the week of October 30th for discussion of moving paper
forward. Alice will update committee after the meeting.
Stephanie to check on the status of Lila's paper "Breast Cancer and HRT in
Perspective" (BC #4) to be published in The Female Patient. (Note: Paper was
published in Primary Care Edition in October)
DW will follow-up with Gallagher on The Role of Estrogens in the Management
of Postmenopausal Bone Loss (SERMS #3) paper after ASRM
.
Update of additional papers in pipeline
Raymond Ke sent HRT and Immune Function paper (BB #4) to Women's
Health in Primary Care on 9/18/00.
Galley proofs received for Macular degeneration and HRT paper (BB #2).
Paper should be published in Nov/Dec issue.
Trudy Bush's review paper (BC #3) and Michele Curtis' review paper (Rx #1)
were submitted for the JAMA special women's issue.
DW will follow up with Lisa Shulman (BB #3) after ASRM.
Confidential Pursuant to Confidentiality
DUROJ023-001777
Order
Source: https://www.industrydocuments.ucsf.edu/docs/rtcw0217

Answer the question using only the OCR text from a single document page. Return only the answer, with no explanation. Preserve the answer wording from the OCR text when possible.